Study in Subjects With Small Primary Choroidal Melanoma
Public ClinicalTrials.gov record NCT03052127. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 1B/2 Open-Label, Ascending Single and Repeat Dose Clinical Trial Designed to Evaluate the Safety and Efficacy of Light-activated AU-011 for the Treatment of Subjects With Small Primary Choroidal Melanoma
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective is to assess the safety, immunogenicity and efficacy of one of three dose levels and repeat dose regimens of Light-activated AU-011 and one or two laser applications for the treatment of subjects with primary choroidal melanoma.
Study identification
- NCT ID
- NCT03052127
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1, Phase 2
- Enrollment
- 57 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 27, 2017 (Actual)
- Primary completion
- Jan 26, 2021 (Actual)
- Completion
- Jan 26, 2021 (Actual)
- Last update posted
- Feb 1, 2024
2017 – 2021
United States locations
- U.S. sites
- 13
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Retina Associates SW, P.C. | Tucson | Arizona | 85710 | — |
| UCLA Jules Stein Eye Institute | Los Angeles | California | 90095 | — |
| Byers Eye Institute at Stanford University | Palo Alto | California | 94303 | — |
| Retina Consultants of Sacramento | Sacramento | California | 95819 | — |
| Colorado Retina Associates | Denver | Colorado | 80210 | — |
| Massachusetts Eye and Ear Infirmary | Boston | Massachusetts | 02114 | — |
| W. K. Kellogg Eye Center, University of Michigan | Ann Arbor | Michigan | 48105 | — |
| Associated Retinal Consultants, PC | Royal Oak | Michigan | 48073 | — |
| Retina Center | Minneapolis | Minnesota | 55404 | — |
| Columbia University Medical Center | New York | New York | 10027 | — |
| Wills Eye Hospital | Philadelphia | Pennsylvania | 19107 | — |
| Retina Consultants of Carolina, PA | Greenville | South Carolina | 29605 | — |
| Retina Consultants of Houston | Houston | Texas | 77030 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03052127, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 1, 2024 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03052127 live on ClinicalTrials.gov.